20 May 2013
Keywords: bayer/onyx, initiate, ph, iii, nexavar, trial, liver
Article | 01 September 2008
Germany's Bayer HealthCare and the USA's Onyx Pharmaceuticals have initiated a new Phase III trial of Nexavar (sorafenib) in liver ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 September 2008
1 September 2008
17 May 2013
© 2013 thepharmaletter.com